The Association Between Body Mass Index and Remission Rates in Patients With Treatment-Resistant Depression Who Received Intravenous Ketamine

被引：9
|
作者：
Singh, Balwinder [1 ]
Bobo, William V. [2 ]
Rasmussen, Keith G. [1 ]
Stoppel, Cynthia J. [1 ]
Rico, Jose A., Jr. [1 ]
Schak, Kathryn M. [1 ]
Biernacka, Joanna M. [1 ,3 ]
Frye, Mark A. [1 ]
Vande Voort, Jennifer L. [1 ]
机构：
[1] Mayo Clin, Coll Med, Dept Psychiat & Psychol, Depress Ctr, Rochester, MN 55905 USA
[2] Mayo Clin, Coll Med, Dept Psychiat & Psychol, Jacksonville, FL 32224 USA
[3] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
来源：
JOURNAL OF CLINICAL PSYCHIATRY | 2019年 / 80卷 / 06期
关键词：
D-ASPARTATE ANTAGONIST; TRIAL;
D O I：
10.4088/JCP.19l12852
中图分类号：
B849 [应用心理学];
学科分类号：
040203 ;
摘要：
引用
收藏
页数：6
相关论文
共 50 条
  • [41] Intravenous Ketamine Treatment for Adolescents With Treatment-Resistant Depression: Clinical Effects and Impacts on Neural Structure
    Cullen, Kathryn
    Klimes-Dougan, Bonnie
    Lim, Kelvin
    Carstedt, Patricia
    Eberly, Lynn
    Roback, Mark
    Albott, Sophia
    Amatya, Palistha
    Mueller, Bryon
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S493 - S494
  • [42] Symptom modulation and tolerability of intravenous ketamine in treatment-resistant bipolar depression: A retrospective study
    Cuomo, Alessandro
    Pardossi, Simone
    Barilla, Giovanni
    Carmellini, Pietro
    Firenzuoli, Bernardo
    Tarantino, Francesca
    Tinturini, Rebecca
    Fagiolini, Andrea
    JOURNAL OF AFFECTIVE DISORDERS, 2025, 376 : 76 - 83
  • [43] Cognitive Behavior Therapy to Prevent Relapse Following Intravenous Ketamine in Treatment-resistant Depression
    Wilkinson, Samuel T.
    Ostroff, Robert
    Sanacora, Gerard
    Fasula, Madonna
    Griepp, Matthew
    BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 210S - 210S
  • [44] Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report
    Garel, Nicolas
    Greenway, Kyle T. T.
    Dinh-Williams, Le-Anh L.
    Thibault-Levesque, Julien
    Jutras-Aswad, Didier
    Turecki, Gustavo
    Rej, Soham
    Richard-Devantoy, Stephane
    NEUROPSYCHOPHARMACOLOGY, 2023, 48 (12) : 1769 - 1777
  • [45] Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report
    Nicolas Garel
    Kyle T. Greenway
    Lê-Anh L. Dinh-Williams
    Julien Thibault-Levesque
    Didier Jutras-Aswad
    Gustavo Turecki
    Soham Rej
    Stephane Richard-Devantoy
    Neuropsychopharmacology, 2023, 48 : 1769 - 1777
  • [46] Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response
    James W. Murrough
    Le-Ben Wan
    Brian Iacoviello
    Katherine A. Collins
    Carly Solon
    Benjamin Glicksberg
    Andrew M. Perez
    Sanjay J. Mathew
    Dennis S. Charney
    Dan V. Iosifescu
    Katherine E. Burdick
    Psychopharmacology, 2014, 231 : 481 - 488
  • [47] Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response
    Murrough, James W.
    Wan, Le-Ben
    Iacoviello, Brian
    Collins, Katherine A.
    Solon, Carly
    Glicksberg, Benjamin
    Perez, Andrew M.
    Mathew, Sanjay J.
    Charney, Dennis S.
    Iosifescu, Dan V.
    Burdick, Katherine E.
    PSYCHOPHARMACOLOGY, 2014, 231 (03) : 481 - 488
  • [48] The Use of a Series of Ketamine Infusions in Two Patients With Treatment-Resistant Depression
    Messer, Michael
    Haller, Irina V.
    Larson, Pamela
    Pattison-Crisostomo, Julia
    Gessert, Charles E.
    JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 2010, 22 (04) : 442 - 450
  • [49] Navigating Treatment-Resistant Depression: Determining Response and Remission Rates of Electroconvulsive Therapy in Adults After Failed Response to Ketamine Infusions
    Silbersweig, Arielle
    Kim, Jonathan
    Coolidge, Sarah J.
    Tsygankova, Val
    Ma, Tianwen
    McDonald, William
    Hershenberg, Rachel
    Posse, Patricio Riva
    Kitay, Brandon
    Hermida, Adriana P.
    JOURNAL OF ECT, 2024, 40 (03) : E29 - E29
  • [50] Prolonged ketamine infusion modulates limbic connectivity and induces sustained remission of treatment-resistant depression
    Joshua S. Siegel
    Ben J. A. Palanca
    Beau M. Ances
    Evan D. Kharasch
    Julie A. Schweiger
    Michael D. Yingling
    Abraham Z. Snyder
    Ginger E. Nicol
    Eric J. Lenze
    Nuri B. Farber
    Psychopharmacology, 2021, 238 : 1157 - 1169
12345